Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 781	$ 555
Accounts receivable - net of allowance for doubtful accounts of $1 and $4, respectively	360	356
Inventories	315	276
Other current assets	82	63
Total Current Assets	1,538	1,250
Marketable securities	11	20
Property, plant and equipment, net	803	774
Intangible assets, net	822	833
Goodwill	2,075	2,076
Other non-current assets	87	72
TOTAL ASSETS	5,336	5,025
Current Liabilities
Accounts payable	212	210
Product warranty liability	31	32
Current portion of long-term debt	5	6
Deferred revenue	41	41
Other current liabilities	217	212
Total Current Liabilities	506	501
Product warranty liability	36	27
Deferred revenue	95	89
Long-term debt	2,395	2,497
Deferred income taxes	501	519
Other non-current liabilities	152	159
TOTAL LIABILITIES	3,685	3,792
Commitments and Contingencies
STOCKHOLDERS’ EQUITY
Preferred stock, $0.01 par value, 100,000,000 shares authorized, none issued and outstanding	0	0
Paid in capital	1,940	1,891
Accumulated deficit	(239)	(628)
Accumulated other comprehensive loss, net of tax	(51)	(31)
TOTAL STOCKHOLDERS’ EQUITY	1,651	1,233
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY	5,336	5,025
Voting Common Stock
STOCKHOLDERS’ EQUITY
Common stock	1	1
Non-voting Common Stock
STOCKHOLDERS’ EQUITY
Common stock	$ 0	$ 0